The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic riskAntoine Andorin, Vincent Probst, Hervé Le Marec et al.|Heart Rhythm|2017Cited by 75
0332 : QUIDAM Study: assessment of hydroquinidine therapy in the management of Brugada syndrome patients at high arrhythmic risk and implanted with an ICDAntoine Andorin, Vincent Probst, Swanny Fouchard et al.|Archives of Cardiovascular Diseases Supplements|2016Cited by 1